{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:10:12Z","timestamp":1648887012926},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,14]],"date-time":"2012-10-14T00:00:00Z","timestamp":1350172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11239-012-0810-y","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T21:10:46Z","timestamp":1350508246000},"page":"91-95","source":"Crossref","is-referenced-by-count":0,"title":["How one academic medical center has managed potency changes with unfractionated heparin"],"prefix":"10.1007","volume":"36","author":[{"given":"Jeffery","family":"Lalama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maichi T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,14]]},"reference":[{"key":"810_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/HPC.0b013e3181d29713","volume":"9","author":"A Krishnaswamy","year":"2010","unstructured":"Krishnaswamy A et al (2010) The use and limitations of unfractionated heparin. Crit Pathw Cardiol 9:35\u201340","journal-title":"Crit Pathw Cardiol"},{"key":"810_CR2","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","volume":"119","author":"J Hirsh","year":"2001","unstructured":"Hirsh J et al (2001) Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119:64S\u201394S","journal-title":"Chest"},{"issue":"11","key":"810_CR3","first-page":"634","volume":"34","author":"W Alexander","year":"2009","unstructured":"Alexander W (2009) Heparin revisions: a call for heightened vigilance and monitoring. Pharm Ther 34(11):634\u2013638","journal-title":"Pharm Ther"},{"issue":"6","key":"810_CR4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1378\/chest.09-0959","volume":"137","author":"Smith et al.","year":"2010","unstructured":"Smith et al (2010) Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 137(6):1382\u20131390","journal-title":"Chest"},{"key":"810_CR5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"The Gusto Investigators","year":"1993","unstructured":"The Gusto Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673\u2013682","journal-title":"N Engl J Med"},{"issue":"5","key":"810_CR6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1592\/phco.30.5.428","volume":"30","author":"MA Smythe","year":"2010","unstructured":"Smythe MA, Nutescu EA, Wittkowsky AK (2010) Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy 30(5):428\u2013431","journal-title":"Pharmacotherapy"},{"key":"810_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yrtph.2011.04.008","volume":"60","author":"R Honchel","year":"2011","unstructured":"Honchel R et al (2011) A dose-response study in animals to evaluate the anticoagulant effect of the stage 2 unfractionated heparin USP monograph change. Regul Toxicol Pharmacol 60:318\u2013322","journal-title":"Regul Toxicol Pharmacol"},{"key":"810_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/hrt.54.3.243","volume":"54","author":"H Tunstall-Pedoe","year":"1985","unstructured":"Tunstall-Pedoe H (1985) Changing digoxin potency and cardiac mortality in England and Wales 1968\u201376. Br Heart J 54:243\u2013247","journal-title":"Br Heart J"},{"key":"810_CR9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1345\/aph.1P088","volume":"44","author":"JN Riney","year":"2010","unstructured":"Riney JN et al (2010) Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients. Ann Pharmacother 44:1141\u20131151","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-012-0810-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0810-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:57Z","timestamp":1559386917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-012-0810-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,14]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s11239-012-0810-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,14]]}}}